Ikaika Therapeutics, Inc.
Biotechnology company · Oak Park, Illinois, United States
Ikaika Therapeutics, Inc. is a biotechnology company headquartered in Oak Park, Illinois, United States. It has received 1 NIH small-business research grant, $995,938 in total. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2021.
Ikaika Therapeutics at a glance
What does Ikaika Therapeutics do?
US government research funding
1 NIH small-business research grant, $995,938 in total. NIH funding came from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1 million sold (2021).
Frequently asked questions about Ikaika Therapeutics
Where is Ikaika Therapeutics headquartered?
Ikaika Therapeutics, Inc. is headquartered in Oak Park, Illinois, United States.
What does Ikaika Therapeutics do?
Ikaika Therapeutics, Inc. is a biotechnology company.
Similar companies
- Thyreos IncOak Park, Illinois, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences